Evidence is growing that the gut microbiota modulates the host response to
chemotherapeutic drugs, with three main clinical outcomes: facilitation of drug efficacy; …

Discoveries made in the past 5 years indicate that the composition of the intestinal
microbiota has a major influence on the effectiveness of anticancer immunosurveillance and …

Humans share a core intestinal microbiome and yet human microbiome differs by genes,
species, enterotypes (ecology), and gene count (microbial diversity). Achievement of …

Disruption of intestinal microbial communities appears to underlie many human illnesses,
but the mechanisms that promote this dysbiosis and its adverse consequences are poorly …

Background Myelosuppression-related infections remain important causes of morbidity and
mortality in children with acute lymphoblastic leukemia (ALL). Methods By analyzing fecal …

Chemotherapy-induced intestinal mucositis, a painful debilitating condition affecting up to 40–
100% of patients undergoing chemotherapy, can reduce the patients' quality of life, add …

Acute myeloid leukemia (AML) intensive chemotherapy combined with broad-spectrum
antibiotics, leads to gut microbiota dysbiosis promoting pathological conditions and an …

Colorectal cancer (CRC) is a common and lethal disease with a high therapeutic need. For
most patients with metastatic CRC, chemotherapy is the only viable option. Currently …

Acute leukemias are a group of aggressive malignant diseases associated with a high
degree of morbidity and mortality. An important cause of both the latter is infectious …

Background The majority of studies that provide insights into the influence of the microbiome
on the health of hematologic malignancy patients have concentrated on the transplant …